Dermoscribe Psoriasis
NDC Package 69683-201-11

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Dermoscribe Psoriasis is for use only by persons over 12 years old. Marketed by Dermoscribe Pty Ltd, this product is identified by NDC 69683-201 and is authorized under FDA application part358H.

Identification & Billing

NDC Package Code
69683-201-11
Package Description
60 g in 1 BOTTLE
Product Code
69683-201
11-Digit Billing Format
69683020111
RxNorm Crosswalk
  • RxCUI: 244475 - coal tar 5 % / salicylic acid 3 % Topical Cream
  • RxCUI: 244475 - coal tar 50 MG/ML / salicylic acid 30 MG/ML Topical Cream

Clinical Specifications

Proprietary Name
Dermoscribe Psoriasis
Dosage Form
-
Usage Information
For use only by persons over 12 years old. Apply in a thin layer over the affected area once or twice daily as required.Use only in accordance with the directions on the label and within the packaging. Refer to enclosed leaflet for detailed directions.

Regulatory & Marketing

Labeler Name
Dermoscribe Pty Ltd
FDA Application #
part358H
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-21-2016
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69683-201-11 identifies a specific commercial package of 60 g in 1 bottle of Dermoscribe Psoriasis, labeled by Dermoscribe Pty Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dermoscribe Pty Ltd on February 21, 2016. The current certification is valid through December 31, 2023.

How is this Dermoscribe Pty Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69683020111. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69683-201-11
11-Digit CMS (5-4-2)
69683-0201-11

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.